Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

425 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cumulative incidence of second intestinal resection in Crohn's disease: a systematic review and meta-analysis of population-based studies.
Frolkis AD, Lipton DS, Fiest KM, Negrón ME, Dykeman J, deBruyn J, Jette N, Frolkis T, Rezaie A, Seow CH, Panaccione R, Ghosh S, Kaplan GG. Frolkis AD, et al. Among authors: rezaie a. Am J Gastroenterol. 2014 Nov;109(11):1739-48. doi: 10.1038/ajg.2014.297. Epub 2014 Oct 21. Am J Gastroenterol. 2014. PMID: 25331349 Review.
Budesonide for maintenance of remission in Crohn's disease.
Kuenzig ME, Rezaie A, Seow CH, Otley AR, Steinhart AH, Griffiths AM, Kaplan GG, Benchimol EI. Kuenzig ME, et al. Among authors: rezaie a. Cochrane Database Syst Rev. 2014 Aug 21;2014(8):CD002913. doi: 10.1002/14651858.CD002913.pub3. Cochrane Database Syst Rev. 2014. PMID: 25141071 Free PMC article. Review.
Comparative effectiveness of immunosuppressants and biologics for inducing and maintaining remission in Crohn's disease: a network meta-analysis.
Hazlewood GS, Rezaie A, Borman M, Panaccione R, Ghosh S, Seow CH, Kuenzig E, Tomlinson G, Siegel CA, Melmed GY, Kaplan GG. Hazlewood GS, et al. Among authors: rezaie a. Gastroenterology. 2015 Feb;148(2):344-54.e5; quiz e14-5. doi: 10.1053/j.gastro.2014.10.011. Epub 2014 Oct 16. Gastroenterology. 2015. PMID: 25448924
Reply: To PMID 25448924.
Hazlewood GS, Rezaie A, Kaplan GG. Hazlewood GS, et al. Among authors: rezaie a. Gastroenterology. 2015 Jun;148(7):1484. doi: 10.1053/j.gastro.2015.04.042. Epub 2015 Apr 30. Gastroenterology. 2015. PMID: 25935530 No abstract available.
Budesonide for induction of remission in Crohn's disease.
Rezaie A, Kuenzig ME, Benchimol EI, Griffiths AM, Otley AR, Steinhart AH, Kaplan GG, Seow CH. Rezaie A, et al. Cochrane Database Syst Rev. 2015 Jun 3;2015(6):CD000296. doi: 10.1002/14651858.CD000296.pub4. Cochrane Database Syst Rev. 2015. PMID: 26039678 Free PMC article. Review.
Ulcerative Colitis Patients With Clostridium difficile are at Increased Risk of Death, Colectomy, and Postoperative Complications: A Population-Based Inception Cohort Study.
Negrón ME, Rezaie A, Barkema HW, Rioux K, De Buck J, Checkley S, Beck PL, Carroll M, Fedorak RN, Dieleman L, Panaccione R, Ghosh S, Kaplan GG. Negrón ME, et al. Among authors: rezaie a. Am J Gastroenterol. 2016 May;111(5):691-704. doi: 10.1038/ajg.2016.106. Epub 2016 Apr 19. Am J Gastroenterol. 2016. PMID: 27091322
Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysis.
Coward S, Kuenzig ME, Hazlewood G, Clement F, McBrien K, Holmes R, Panaccione R, Ghosh S, Seow CH, Rezaie A, Kaplan GG. Coward S, et al. Among authors: rezaie a. Inflamm Bowel Dis. 2017 Mar;23(3):461-472. doi: 10.1097/MIB.0000000000001023. Inflamm Bowel Dis. 2017. Corrected and republished in: Inflamm Bowel Dis. 2017 May 1;23(5):E26-E37. doi: 10.1097/MIB.0000000000001158 PMID: 28146003 Corrected and republished. Review.
425 results